Invesco Mutual Fund Reports 5.0273% Stake in Global Health Limited Under SEBI Regulation 29

2 min read     Updated on 23 Feb 2026, 04:22 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Invesco Mutual Fund disclosed crossing the 5% threshold in Global Health Limited, with aggregate holding reaching 5.0273% as of February 20, 2026. The fund acquired 10,01,873 shares through open market purchases, increasing total holding from 4.6546% to 5.0273%. The investment spans across 14 Invesco schemes, with the disclosure made under SEBI Regulation 29(1) for substantial acquisitions.

33389544

*this image is generated using AI for illustrative purposes only.

Invesco Mutual Fund has reported a substantial acquisition disclosure for Global Health Limited under SEBI Regulation 29(1), with the fund house crossing the 5% threshold in the healthcare company's equity shares. The disclosure, dated February 23, 2026, indicates that Invesco's aggregate holding reached 5.0273% of Global Health Limited's paid-up share capital as of the close of business hours on February 20, 2026.

Acquisition Details

The mutual fund acquired 10,01,873 shares through open market transactions, representing 0.3727% of the total share capital. This acquisition increased Invesco's total holding from 1,25,11,138 shares to 1,35,13,011 shares.

Parameter Before Acquisition Acquisition After Acquisition
Number of Shares 1,25,11,138 10,01,873 1,35,13,011
Percentage Holding 4.6546% 0.3727% 5.0273%
Mode of Acquisition - Open Market -
Date of Acquisition - February 20, 2026 -

Participating Schemes

The investment was made across 14 different Invesco schemes, demonstrating diversified participation from the fund house's portfolio:

  • Invesco India Business Cycle Fund
  • Invesco India Aggressive Hybrid Fund
  • Invesco India ESG Integration Strategy Fund
  • Invesco India Flexi Cap Fund
  • Invesco India Focused Fund
  • Invesco India Consumption Fund
  • Invesco India Smallcap Fund
  • Invesco India Largecap Fund
  • Invesco India Contra Fund
  • Invesco India Large & Mid Cap Fund
  • Invesco India Infrastructure Fund
  • Invesco India Midcap Fund
  • Invesco India Multicap Fund
  • Invesco India ELSS Tax Saver Fund

Company Information

Global Health Limited maintains its equity share capital at Rs. 53,75,80,764, comprising 26,87,90,382 equity shares of Re. 2 each. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.

Company Details Information
Equity Share Capital Rs. 53,75,80,764
Number of Shares 26,87,90,382
Face Value per Share Re. 2
Stock Exchanges BSE Limited, NSE

Regulatory Compliance

The disclosure was made in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Hardik Mehta, Chief Risk Officer at Invesco Asset Management (India) Private Limited, signed the disclosure document. The notification confirms that Invesco does not belong to the promoter or promoter group of Global Health Limited.

The disclosure was simultaneously communicated to Global Health Limited's management and the listing departments of both BSE Limited and National Stock Exchange of India Limited, ensuring full regulatory compliance and transparency in the substantial acquisition process.

Historical Stock Returns for Global Health

1 Day5 Days1 Month6 Months1 Year5 Years
+3.19%+2.36%+8.39%-15.38%-3.35%+180.76%

Global Health Limited Receives ESG Rating of 69 for FY25 from NSE Sustainability Ratings & Analytics

1 min read     Updated on 20 Feb 2026, 01:33 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Global Health Limited received an ESG rating of 69 for Financial Year 2025 from NSE Sustainability Ratings & Analytics Limited, as disclosed in a regulatory filing dated February 20, 2026. The company made this announcement in compliance with SEBI Listing Regulations to both BSE and NSE, where it trades under scrip code 543654 and symbol MEDANTA respectively. Company Secretary Rahul Ranjan signed the formal communication, ensuring regulatory compliance for this material disclosure to investors and stakeholders.

33120224

*this image is generated using AI for illustrative purposes only.

Global Health Limited has received an ESG rating of 69 for Financial Year 2025 from NSE Sustainability Ratings & Analytics Limited, the company announced through a regulatory filing on February 20, 2026.

Regulatory Compliance and Filing Details

The disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company filed the intimation with both major stock exchanges where its shares are listed.

Parameter: Details
ESG Rating: 69
Rating Agency: NSE Sustainability Ratings & Analytics Limited
Assessment Period: Financial Year 2025
Filing Date: February 20, 2026
Reference Number: GHL/2025-26/EXCH/108

Stock Exchange Communication

The formal communication was addressed to both BSE Limited and National Stock Exchange of India Limited. The company trades under scrip code 543654 on BSE and symbol MEDANTA on NSE. The filing ensures compliance with regulatory requirements for disclosure of material information to investors and stakeholders.

Corporate Governance

The regulatory filing was executed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035), who digitally signed the document on February 20, 2026, at 13:11:03 +05'30'. The communication emphasized that this information is provided for the exchanges' information and record purposes.

ESG ratings assess companies on environmental, social, and governance parameters, providing investors and stakeholders with insights into corporate sustainability practices and responsible business conduct.

Historical Stock Returns for Global Health

1 Day5 Days1 Month6 Months1 Year5 Years
+3.19%+2.36%+8.39%-15.38%-3.35%+180.76%

More News on Global Health

1 Year Returns:-3.35%